SL
Samsung Life Science Fund
Venture Capital
Corporate venture fund backed by Samsung C&T, Samsung Biologics, and Samsung Bioepis, investing in global biotech with innovative therapeutic technologies.
Seoul, South Korea · 3+ investments
Early Stage
Growth
Biotech
Gene Therapy
Life Sciences
- Headquarters
- Seoul, South Korea
- Founded
- 2021
- AUM
- $320.0M
- Total Investments
- 3
- Last Investment
- May 2024
- Geographic Focus
- Europe, Global, South Korea, United States
Investment Thesis
Invests in advanced biopharmaceutical technologies — gene therapy, ADCs, AI drug discovery — to secure strategic collaborations and advance Samsung's global biotech network.
Samsung Life Science Fund is a Venture Capital firm based in Seoul, South Korea. It has made 3 investments in Biotech and Gene Therapy.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.